US2006142197A1PendingUtilityA1

TNF receptor and steroid hormone in a combined therapy

Assignee: APPLIED RESEARCH SYSTEMSPriority: Jul 14, 1995Filed: Feb 13, 2006Published: Jun 29, 2006

Est. expiryJul 14, 2015(expired)· nominal 20-yr term from priority

Inventors:Alessandra Boe Francesco Borrelli

A61K 38/1793A61K 31/56

PatentIndex Score

Cited by

References

Claims

Abstract

The present invention relates to the use of a TNF Receptor together with a steroid hormone to produce a pharmaceutical composition for the treatment of lethal bacterial and viral infections as well as autoimmune and inflammatory diseases. It also relates to said pharmaceutical compositions for the simultaneous separate or sequential use of its active ingredients for the above specified treatment. In particular, it relates to the use of TBP-1, together with dehydroepiandrosterone (DHEA) or its metabolites to produce a pharmaceutical composition for the treatment of septic shock.

Claims

exact text as granted — not AI-modified

1 . A method for treating lethal virus infections in a patient which comprises administering to a patient a tumor necrosis factor (TNF) receptor in combination with dehydroepiandrosterone (DHEA) simultaneously, separately or sequentially.  
     
     
         2 . The method of claim  18 , wherein the TNF receptor is TNF Binding Protein-2.  
     
     
         3 . The method of claim  18 , wherein the TNF receptor is TNF Binding Protein-1.

Join the waitlist — get patent alerts

Track US2006142197A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.